1. Home
  2. ATRC vs BHE Comparison

ATRC vs BHE Comparison

Compare ATRC & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • BHE
  • Stock Information
  • Founded
  • ATRC 2000
  • BHE 1979
  • Country
  • ATRC United States
  • BHE United States
  • Employees
  • ATRC N/A
  • BHE N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • BHE Electrical Products
  • Sector
  • ATRC Health Care
  • BHE Technology
  • Exchange
  • ATRC Nasdaq
  • BHE Nasdaq
  • Market Cap
  • ATRC 1.6B
  • BHE 1.3B
  • IPO Year
  • ATRC 2005
  • BHE 1990
  • Fundamental
  • Price
  • ATRC $31.76
  • BHE $40.32
  • Analyst Decision
  • ATRC Strong Buy
  • BHE Strong Buy
  • Analyst Count
  • ATRC 10
  • BHE 2
  • Target Price
  • ATRC $49.60
  • BHE $47.00
  • AVG Volume (30 Days)
  • ATRC 424.4K
  • BHE 279.8K
  • Earning Date
  • ATRC 07-29-2025
  • BHE 07-29-2025
  • Dividend Yield
  • ATRC N/A
  • BHE 1.69%
  • EPS Growth
  • ATRC N/A
  • BHE N/A
  • EPS
  • ATRC N/A
  • BHE 1.44
  • Revenue
  • ATRC $480,076,000.00
  • BHE $2,612,294,000.00
  • Revenue This Year
  • ATRC $14.63
  • BHE $0.52
  • Revenue Next Year
  • ATRC $12.62
  • BHE $8.50
  • P/E Ratio
  • ATRC N/A
  • BHE $27.98
  • Revenue Growth
  • ATRC 15.79
  • BHE N/A
  • 52 Week Low
  • ATRC $20.20
  • BHE $30.73
  • 52 Week High
  • ATRC $43.11
  • BHE $52.57
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 44.34
  • BHE 67.14
  • Support Level
  • ATRC $30.85
  • BHE $38.01
  • Resistance Level
  • ATRC $33.15
  • BHE $39.77
  • Average True Range (ATR)
  • ATRC 0.98
  • BHE 0.92
  • MACD
  • ATRC -0.10
  • BHE 0.17
  • Stochastic Oscillator
  • ATRC 36.52
  • BHE 92.91

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia and Europe of which key revenue is derived from the Americas.

Share on Social Networks: